The decreased expression of FAS may keep the transformed cells from elimination by antitumor immune response, called immune escape while the increased expression of FASL may increase the ability of tumor cells to kill FAS-sensitive lymphocytes, called immune counterattack [53]. The gene discussed is FAS; the disease is neoplasm.